Evidence map›Paper›PMID 36591911›Full record

ReviewInternational journal of surgical pathology2023

Pedram Argani, Andres Matoso, Ezra G Baraban, Jonathan I Epstein, Cristina R Antonescu

Open access · greenAbstract readReviewCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of surgical pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Cancers · 2026
    Review
  3. Review
  4. Paediatric renal tumours: an update on challenges and recent developments.Virchows Archiv : an international journal of pathology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Pedram ArganiDepartment of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.ORCID 0000-0001-8797-9474
Andres MatosoDepartment of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.ORCID 0000-0003-0990-1115
Ezra G BarabanDepartment of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Jonathan I EpsteinDepartment of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Cristina R AntonescuDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Johns Hopkins University · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Targeting Oncogenic Pathways in Genetically Complex SarcomasP50CA217694 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI William D. Tap · 2018 to 2026
$21.5M
NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA217694
6 · The paper itself

Abstract

We report two novel cases of Xp11 translocation renal cell carcinomas with the

Indexed as

Carcinoma, Renal CellCystsKidney NeoplasmsAdultBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsChromosomes, Human, XFemaleGlycineHumansMediator ComplexPyrrolesTranslocation, GeneticBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsGlycineMED15 protein, humanMediator ComplexPyrrolesST 679TFE3 protein, humanMED15: translocationrenal neoplasmTFE3

Identifiers

PMID36591911
PMCPMC10175165
OpenAlexW4313424531

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.